Microcaps
Innovative microencapsulation technology for cosmetics, food, and pharma: Swiss droplet science enabling next-generation consumer and health products.
- Sector
- Microencapsulation
- HQ
- Switzerland
- Employees
- 20-30
- Since
- 2020
- Transaction
- Growth Capital
- Participation
- Minority
- Vehicle
- Helvetica Capital
About
Company Overview
Microcaps is a Swiss innovation company that has developed a proprietary microfluidic technology platform for producing microcapsules with exceptional precision and consistency. The company's encapsulation solutions serve three major industries (cosmetics, food, and pharmaceuticals) where the ability to deliver and release active ingredients at the right moment is critical to product performance.
Traditional encapsulation methods often produce capsules with wide size variation and inconsistent release profiles. Microcaps' microfluidic approach solves this problem at its root: by controlling the encapsulation process at the micro-scale, the company delivers uniform capsules with predictable behaviour. For a cosmetics manufacturer, this means more reliable product performance on the shelf.
Despite its small team of 20 to 30 specialists, Microcaps operates with a global outlook, serving customers and development partners across multiple continents. The company sits at the intersection of materials science, process engineering, and applied chemistry and is focusing on the fragrance sector.
Partnership
Our Partnership
Helvetica Capital invested in Microcaps in December 2020, drawn by the company's differentiated technology and the breadth of industries it can serve from a single platform. As a minority partner, we provide strategic guidance and entrepreneurial perspective to a team that is navigating the transition from technology development to commercial scale.
Every exit is a completed story.
When we transition a company, it is from a position of strength, including to international groups.